Rutgers The State University of New Jersey-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Rutgers The State University of New Jersey - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013176
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rutgers The State University of New Jersey (Rutgers) is a research university that offers undergraduate and postgraduate programs, and research in the areas of health sciences. The university provides continuing education for professional and personal advancement. It offers courses in the areas of accounting and information systems, aerospace engineering, Africana studies, agricultural and resource management agents, agricultural, food, and resource economics, environmental sciences, epidemiology, and others. Rutgers operates through its campuses in New Brunswick, Newark, and Camden. The university provides services, solutions, and clinical care for individuals and the local, national, and global communities. Rutgers is headquartered in New Brunswick, New Jersey, the US.

Rutgers The State University of New Jersey – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Rutgers The State University of New Jersey, Medical Devices Deals, 2011 to YTD 2017 9
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
BioMotiv Forms Joint Venture with Rutgers University 12
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 13
Regent Surgical Health Forms Joint Venture With Robert Wood Johnson University Hospital 14
Proteonomix Enters Into Co-Development Agreement With University of Medicine and Dentistry For UMK-121 Technology 15
Licensing Agreements 16
Biohaven Pharma Enters into Licensing Agreement with Rutgers, The State University of New Jersey 16
Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 18
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 20
Biosearch Technologies Extends Licensing Agreement With University Of Medicine And Dentistry Of New Jersey For Stellaris RNA FISH Technology 21
WaferGen Biosystems Enters Into Licensing Agreement With Rutgers University For RNA Quality Control Technology 22
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 23
Rutgers The State University of New Jersey – Key Competitors 24
Rutgers The State University of New Jersey – Key Employees 25
Rutgers The State University of New Jersey – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 27
Recent Developments 28
Strategy And Business Planning 28
Feb 29, 2016: Z53 Therapeutics, A New Oncology Start-Up, Launches to Combat Cancer-Associated Mutation 28
Government and Public Interest 29
Feb 17, 2016: Cancer Study is ‘Paradigm Shift’ in Cause of Tumor Formation 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Key Facts 2
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rutgers The State University of New Jersey, Deals By Therapy Area, 2011 to YTD 2017 8
Rutgers The State University of New Jersey, Medical Devices Deals, 2011 to YTD 2017 9
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
BioMotiv Forms Joint Venture with Rutgers University 12
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 13
Regent Surgical Health Forms Joint Venture With Robert Wood Johnson University Hospital 14
Proteonomix Enters Into Co-Development Agreement With University of Medicine and Dentistry For UMK-121 Technology 15
Biohaven Pharma Enters into Licensing Agreement with Rutgers, The State University of New Jersey 16
Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 18
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 20
Biosearch Technologies Extends Licensing Agreement With University Of Medicine And Dentistry Of New Jersey For Stellaris RNA FISH Technology 21
WaferGen Biosystems Enters Into Licensing Agreement With Rutgers University For RNA Quality Control Technology 22
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 23
Rutgers The State University of New Jersey, Key Competitors 24
Rutgers The State University of New Jersey, Key Employees 25
Rutgers The State University of New Jersey, Other Locations 26
Rutgers The State University of New Jersey, Subsidiaries 26
Rutgers The State University of New Jersey, Joint Venture 27

★海外企業調査レポート[Rutgers The State University of New Jersey-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Optus Inc:企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Renaissance Offshore LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Renaissance Offshore LLC (Renaissance Offshore) is an oil and gas exploration and development company. The company carries out the business of identification and acquisition of under-developed oil and gas assets in the Gulf of Mexico. It builds and manages a portfolio of assets on oil produc …
  • Korea Petrochemical Ind. Co Ltd (006650):企業の財務・戦略的SWOT分析
    Summary Korea Petrochemical Ind. Co Ltd (KPICL) is a chemical company that manufactures and markets petrochemical products. The company provides products such as olefins, aromatics, polypropylene, EO and EG, PP and HDPE. It provides olefins products such as ethylene, propylene, butene, butane, isobu …
  • Vascular Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary Vascular Solutions Inc (Vascular Solutions), a subsidiary of Teleflex Inc, is a medical device company that develops and markets clinical solutions for coronary and peripheral vascular procedures. The company’s portfolio spans various types of catheters used for simultaneous pressure measure …
  • Wilson Therapeutics AB (WTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Wilson Therapeutics AB (Wilson Therapeutics), a subsidiary of Alexion Pharma Nordics AB, is a biopharmaceutical company that develops novel therapies for patients with rare copper-mediated disorders. The company’s lead product includes WTX101 is a copper-protein-binding agent, which is used …
  • Delta Electronics (Thailand) Public Company Ltd. (DELTA):企業の財務・戦略的SWOT分析
    Delta Electronics (Thailand) Public Company Ltd. (DELTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company …
  • Tunstall Americas:企業の戦略的SWOT分析
    Tunstall Americas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Arkle Resources Plc
    Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Meiji Yasuda Life Insurance Company
    Meiji Yasuda Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Meiji Yasuda Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Silex Systems Ltd (SLX):企業の財務・戦略的SWOT分析
    Summary Silex Systems Ltd (Silex) is a research and development company that offers technology solutions. The company develops, and commercializes technologies in solar energy, nuclear energy, and advanced materials and instrumentation. It develops utility-scale concentrating photovoltaic technology …
  • Inventec Corporation (2356):企業の財務・戦略的SWOT分析
    Inventec Corporation (2356) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • S2Medical AB:製品パイプライン分析
    Summary S2Medical AB (S2Medical) is a medical technology company that designs, develops and markets wound dressings and products to treat burns and chronic ulcers. The company’s product portfolio consists of wound dressing patches; blood stilling synthetic epithelium dressing to control capillary bl …
  • Banco Bilbao Vizcaya Argentaria SA:戦略・SWOT・企業財務分析
    Banco Bilbao Vizcaya Argentaria SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bilbao Vizcaya Argentaria SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Leroy Seafood Group ASA:企業の戦略・SWOT・財務情報
    Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report Summary Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ashland Global Holdings Inc (ASH):企業の財務・戦略的SWOT分析
    Ashland Global Holdings Inc (ASH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • IDT Corporation:企業の戦略・SWOT・財務情報
    IDT Corporation - Strategy, SWOT and Corporate Finance Report Summary IDT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cepheid:医療機器:M&Aディール及び事業提携情報
    Summary Cepheid, a subsidiary of Danaher Corporation, is a molecular diagnostic company that develops, manufactures and markets molecular systems and tests for clinical and non-clinical markets. The company offers in vitro diagnostic tests for health care associated infections, critical infectious d …
  • Aclara Technologies LLC-エネルギー分野:企業M&A・提携分析
    Summary Aclara Technologies LLC (Aclara), as a subsidiary of Sun Capital Partners, Inc. The company designs, develops and commercializes Advanced Metering Infrastructure (AMI) solutions for data value management, customer communication and device networking activities. It provides an array of custom …
  • Lion Energy Ltd (LIO):企業の財務・戦略的SWOT分析
    Summary Lion Energy Ltd (Lion) is an oil and gas company that explores, develops and produces unconventional oil and gas resources in Indonesia. The company has conventional production sharing contracts such as Seram project and South Block A project. Its Seram project is located on the island of Se …
  • ERI Bancaire SA:企業の戦略的SWOT分析
    ERI Bancaire SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆